Board of Trustees of The Leland Stanford Junior University Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$326M |
| 2 |
LNW
Light & Wonder
LNW
|
+$37.3M |
| 3 |
Alto Neuroscience
ANRO
|
+$3.23M |
| 4 |
LENZ
LENZ Therapeutics
LENZ
|
+$1.74M |
| 5 |
Personalis
PSNL
|
+$18.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 3.27% |
| 2 | Healthcare | 1.4% |
| 3 | Technology | 0.59% |
| 4 | Energy | 0.44% |
| 5 | Industrials | 0.04% |
Similar funds
Board of Trustees of The Leland Stanford Junior University's Q3 2024 Portfolio in Review
As of Q3 2024, Board of Trustees of The Leland Stanford Junior University held 28 positions worth $1.17B, down 20% from $1.47B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Board of Trustees of The Leland Stanford Junior University withdrew a net $368M in Q3 2024, closing 3 positions and reducing 3 holdings. Its most notable exit was LENZ Therapeutics, an estimated $1.74M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 3.3% of assets, down from 5.3% a quarter earlier, followed by Healthcare and Technology.
- Board of Trustees of The Leland Stanford Junior University's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $326M.
- Board of Trustees of The Leland Stanford Junior University fully exited LENZ Therapeutics in Q3 2024, selling an estimated $1.74M.
- Board of Trustees of The Leland Stanford Junior University's ten largest holdings make up 99% of its $1.17B portfolio in Q3 2024.
- Board of Trustees of The Leland Stanford Junior University opened 0 new positions and closed 3 in Q3 2024.
- Board of Trustees of The Leland Stanford Junior University's portfolio value fell 20% quarter-over-quarter to $1.17B.
Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q3 2024, filed 12 Nov 2024.